Treatment of alcohol withdrawal
96 results
1 - 96
Treatment of alcohol withdrawal 
Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses- Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome
- Benzodiazepines for alcohol withdrawal
- Neurological disorders and alcohol
- Benzodiazepines for alcohol withdrawal
- Anticonvulsants for alcohol withdrawal
- Magnesium for alcohol withdrawal: Cochrane systematic review
Nalmefene may not be effective for alcohol withdrawal- Baclofen for alcohol withdrawal
- Treatment of drug addicts
- Providing care for an alcohol or drug abuser
- Psychotropic analgesic nitrous oxide for alcoholic withdrawal states
- Dual diagnosis
- Naltrexone for smoking withdrawal
- Benzodiazepines for delirium
- Magnesium and alcohol withdrawal syndrome
- A patient with legal drug addiction in primary care
- Long-term benzodiazepine use and withdrawal
- aDrugs commonly causing poisonings
- Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment
- Pharmacotherapy for anxiety and comorbid alcohol use disorders
- Anticonvulsants for alcohol dependence: Cochrane systematic review
- Home visits during pregnancy and after birth for women with an alcohol or drug problem
- Thiamine for prevention and treatment of Wernicke‐Korsakoff Syndrome in people who abuse alcohol
- Gabapentin increases short-term alcohol abstinence in motivated patients
- Perioperative alcohol cessation intervention for postoperative complications
- Drugs used in alcohol dependence
- Antidepressants for co-occurring depression and alcohol dependence
- Delirium in the elderly
- Alpha 2 -adrenergic agonists for the management of opioid withdrawal: Cochrane systematic review
- Alcohol poisoning
- Antidepressants for the treatment of people with co-occurring depression and alcohol dependence: Cochrane systematic review
- Pregnant substance abuser
- Acute psychosis
- Encountering a violent or threatening patient
- Nalmefene for alcohol dependence
- Naltrexone for alcohol dependence
- Music therapy for people with substance use disorders
- Anxiety disorder
- Eszopiclone for insomnia: Cochrane systematic review
- Benzodiazepines for schizophrenia: Cochrane systematic review
- Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit
- Acupuncture
- Mental disorders due to somatic disease
- Oral CBD promising for treatment of heroin use disorder
- Treatment of poisoning
- Slow-release oral morphine as maintenance therapy for opioid dependence: Cochrane systematic review
- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification
- Quetiapine + haloperidol = faster resolution of ICU delirium
- Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
- Plugs for containing faecal incontinence
- Urinary incontinence in the elderly
- Diagnosis of epilepsy: definitions and workup
- Maintenance agonist treatments for opiate‐dependent pregnant women
- Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation
- Psychosocial interventions for benzodiazepine harmful use, abuse or dependence
- Pharmacological treatment of depression
- Smoking cessation
- Functional bowel disorders and the irritable bowel syndrome (IBS)
- Headache
- Treatment of dyslipidaemias